Publication | Closed Access
Teriflunomide added to interferon-β in relapsing multiple sclerosis
78
Citations
13
References
2012
Year
This study provides Class II evidence that teriflunomide, 7 and 14 mg, added to IFNβ, is safe. The T1-Gd lesion burden was significantly reduced with both teriflunomide doses.
| Year | Citations | |
|---|---|---|
Page 1
Page 1